Skip to main content

Court Turner

Partner

Mr. Turner is founding President, CEO & Chair of Onchilles Pharma and is a Partner at LYZZ Capital Advisors. Mr. Turner has more than 25 years of experience in the San Diego life science community. LYZZ currently has six (6) portfolio companies in San Diego, including Neurelis, Wugen and JumpCode Genomics. Prior to cofounding Onchilles with Dr. Lev Becker, Mr. Turner was a venture partner at Avalon Ventures for a decade. During his time at Avalon, he was also the founding CEO and director of Synthorx, Inc. (acquired by Sanofi) and founding chairman and CEO of RQx Pharmaceuticals (transaction with Genentech). Before Avalon, he served as a member of the executive management teams at Kalypsys, Inc. and Aurora Biosciences (acquired by Vertex Pharmaceuticals). He also is a part-time professor at San Diego State University (SDSU) where he teaches a class titled, “From Invention to Patient” in the College of Sciences. Mr. Turner received his J.D. from the University of San Diego School of Law and a B.S. in psychology from SDSU.